Ginkgo Bioworks Inc.
DNA | NYSE
$7.98
+$0.10 (+1.27%)
At close: Sep 21, 2026, 4:00 PM ET
$7.86
-$0.12 (-1.50%)
Pre-market:
Sep 22, 2026, 7:54 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 111.86M | 141.31M | 170.16M | 180.61M | 230.82M | 237.42M | 227.04M | 217.95M | 184.34M | 208.7M | 251.46M | 314.99M | 325.95M | 390M | 477.71M | 527.92M | 539.13M | 438.15M | 313.84M | 197.4M | 133.09M | 99.62M |
Cost of Revenue | 22.27M | 35.37M | 31.52M | 49.29M | 46.48M | 45.38M | 42.53M | 39.52M | 36.46M | 40.83M | 54.01M | 77.61M | 95.34M | 141.16M | 204.22M | 240.58M | 238.22M | 191.42M | 129.69M | 76.95M | 56.42M | 39.31M |
Gross Profit | 89.6M | 105.94M | 138.63M | 131.31M | 184.34M | 192.04M | 184.51M | 178.43M | 147.88M | 167.87M | 197.45M | 237.37M | 230.61M | 248.84M | 273.49M | 287.34M | 300.9M | 246.72M | 184.15M | 120.45M | 76.67M | 60.31M |
Operating Income | -290.69M | -297.68M | -315.28M | -348.13M | -313.32M | -470.72M | -559.76M | -634.27M | -865.46M | -826.66M | -864.41M | -920.8M | -1.29B | -1.75B | -2.21B | -3.66B | -3.03B | -2.45B | -1.83B | -199.62M | -207.36M | -178.47M |
Interest Income | 53.43M | 56.28M | 58.77M | 25.24M | 28.75M | 32.98M | 38.61M | 44.58M | 50.35M | 54.38M | 57.22M | 55.33M | 46.69M | 34.6M | 20.06M | 9.14M | 2.88M | 617K | 617K | 121K | 3.32M | 3.49M |
Pretax Income | -295.48M | -298.87M | -313.6M | -340.07M | -316.09M | -472.5M | -547.51M | -651.54M | -897.68M | -853.93M | -892.94M | -869.97M | -1.24B | -1.73B | -2.12B | -3.54B | -2.97B | -2.36B | -1.84B | -278.84M | -202.34M | -176.17M |
Net Income | -290.8M | -304.39M | -312.76M | -339.55M | -315.19M | -472.08M | -547.03M | -651.19M | -897.68M | -853.81M | -892.87M | -857.72M | -1.22B | -1.72B | -2.11B | -3.53B | -2.96B | -2.35B | -1.83B | -276.32M | -200.49M | -175.21M |
Selling & General & Admin | 159.57M | 172.08M | 183.29M | 194.57M | 201.91M | 224.92M | 246.16M | 278.09M | 307.82M | 343.88M | 385.03M | 417.22M | 770.42M | 1.11B | 1.43B | 2.09B | 1.68B | 1.28B | 862.95M | 94.24M | 75.16M | 49.67M |
Research & Development | 215.61M | 222.77M | 243.77M | 270.02M | 277.68M | 358.53M | 424.06M | 464.72M | 544.38M | 554.44M | 580.62M | 644.74M | 749.54M | 895.31M | 1.06B | 1.86B | 1.65B | 1.41B | 1.15B | 225.83M | 208.88M | 189.12M |
Other Expenses | 5.1M | 8.78M | 26.85M | 14.85M | 18.07M | 79.32M | 74.05M | 69.89M | 161.13M | 96.21M | 96.21M | 96.21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 380.29M | 403.62M | 453.91M | 479.45M | 497.66M | 662.76M | 744.27M | 812.7M | 1.01B | 994.53M | 1.06B | 1.16B | 1.52B | 2B | 2.49B | 3.95B | 3.34B | 2.69B | 2.01B | 320.07M | 284.03M | 238.78M |
Interest Expense | n/a | n/a | n/a | 94K | 94K | 94K | 94K | 93K | 93K | 93K | 93K | n/a | n/a | n/a | 397K | 948K | 1.6M | 2.08M | 2.15M | 1.6M | 1.55M | 1.07M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 402.55M | 439M | 485.43M | 528.74M | 544.13M | 708.14M | 786.8M | 852.22M | 1.05B | 1.04B | 1.12B | 1.24B | 1.62B | 2.14B | 2.69B | 4.19B | 3.57B | 2.88B | 2.14B | 397.02M | 340.45M | 278.09M |
Income Tax Expense | -594K | -1.01M | -837K | -519K | -895K | -422K | -479K | -352K | 1K | -122K | -71K | -14.64M | -14.65M | -14.76M | -15.03M | -940K | -1.12M | -1.51M | -1.48M | -789K | -576K | -139K |
Shares Outstanding (Basic) | 62.09M | 59.56M | 55.46M | 55.63M | 54.86M | 54.24M | 51.89M | 52.24M | 51.33M | 49.93M | 49.11M | 48.77M | 48.14M | 47.77M | 45.6M | 40.77M | 40.52M | 39.9M | 36.94M | 33.09M | 32.31M | 32.26M |
Shares Outstanding (Diluted) | 62.09M | 59.56M | 55.46M | 55.63M | 54.86M | 54.24M | 51.89M | 52.25M | 51.38M | 49.99M | 49.47M | 48.77M | 48.34M | 47.92M | 46.42M | 40.77M | 40.52M | 40.19M | 38.29M | 33.09M | 32.31M | 32.26M |
EPS (Basic) | -5.02 | -5.37 | -5.66 | -6.30 | -5.93 | -9.06 | -10.70 | -12.91 | -18.04 | -17.40 | -18.36 | -17.86 | -28.09 | -41.01 | -51.42 | -89.46 | -76.10 | -61.26 | -48.85 | -8.49 | -6.22 | -5.49 |
EPS (Diluted) | -5.02 | -5.37 | -5.66 | -6.30 | -5.93 | -9.06 | -10.70 | -12.94 | -18.07 | -17.44 | -18.41 | -17.95 | -28.18 | -41.09 | -51.60 | -91.09 | -77.73 | -62.89 | -50.37 | -8.51 | -6.24 | -5.51 |
EBITDA | -209.15M | -210.87M | -215.86M | -324.47M | -292.97M | -387.59M | -472.27M | -617.67M | -751.71M | -766.61M | -799.53M | -641.68M | -1.13B | -1.64B | -2.04B | -3.5B | -2.93B | -2.32B | -1.81B | -261.65M | -189.97M | -170.6M |
EBIT | -294.96M | -300.15M | -307.71M | -385.45M | -356.95M | -453.11M | -535.29M | -678.92M | -816.85M | -832.08M | -871.09M | -715.17M | -1.2B | -1.69B | -2.08B | -3.54B | -2.97B | -2.35B | -1.84B | -286.73M | -210.3M | -186.93M |
Depreciation & Amortization | 85.81M | 89.29M | 91.85M | 60.98M | 63.98M | 65.52M | 63.02M | 61.25M | 65.14M | 65.47M | 71.55M | 73.49M | 60.34M | 52.72M | 42.71M | 34.89M | 35.25M | 32.39M | 29.08M | 25.08M | 20.33M | 16.34M |
Add to Watchlist
Select watchlists to add or remove DNA